Opinion
Video
Author(s):
Neal Shore, MD, FACS, discusses how the patient profile in the VISION trial, which involved progression on multiple therapies, reflects typical cases for Lutetium-177 treatment, emphasizing the crucial role of PSMA PET imaging in determining treatment suitability.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.